AI
It has also received Australia's regulatory approval for its AI solution.
The company will build a genAI-enabled expert health coach that personalizes behavioral change.
Also, Kakao Healthcare is extending access to its AI to a public diabetes screening programme in South Korea.
Also, New Zealand's The Doctors has cautioned the public about a mobile app posing as its official app.
It has shown 96% accuracy in predicting fall risks in over 70,000 outpatients in Japan.
The company's first two partners to leverage OMNY's dataset are life sciences company ArisGlobal and clinical trial design company QuantHealth.
Rad AI's genAI tools will be offered through Bayer's vendor-neutral Calantic Digital Solution marketplace, which provides AI-enabled clinical and operational applications.
Also, insurtech company Huize from China is expanding to Southeast Asia.
LifeSemantics plans to commercialise its mobile app-based AI screening solution by yearend.
Cloudphysician targets to enter the United States, the Middle East, and Southeast Asia with its smart ICU and emergency department solutions.